Todas las investigaciones
ReclutamientoOBSERVACIONAL

EORTC Metastatic Breast Cancer Module Development

This study aims to create a new, easy-to-use questionnaire designed specifically for women living with breast cancer that has spread (metastatic breast cancer). At the moment, there isn't a perfect way to fully understand how this condition affects a woman's daily life and wellbeing. This new tool will help doctors and researchers get a clearer picture of patients' quality of life, including their physical and emotional experiences. By doing this, they hope to improve the support and care offered. The questionnaire will be developed with direct input from patients across Europe to ensure it accurately reflects their experiences.

De un vistazo

Estado
Reclutamiento
Patrocinador
University of Leeds
Objetivo de inscripción
568
Inicio
01 May 2020
Estimación de finalización
31 May 2029

¿De qué trata este estudio?

When breast cancer spreads to other parts of the body, it's called metastatic breast cancer. Living with this condition can bring many challenges, both physically and emotionally, and it can significantly impact a person's quality of life. At the moment, there isn't a specific tool that fully captures all these experiences in a comprehensive way.

This project aims to fill that gap by developing a brand new questionnaire. This questionnaire will help healthcare teams and researchers better understand how treatments and the condition itself affect women's daily lives. It will cover various aspects, such as physical symptoms, emotional wellbeing, social life, and how able patients are to do everyday activities. By having a clearer picture of these experiences, doctors can offer more tailored support and care.

The development of this questionnaire will involve speaking directly with women who have metastatic breast cancer from different hospitals across Europe. Their experiences and feedback will be key to making sure the new questionnaire truly reflects what matters most to patients. This new tool will be used alongside an existing questionnaire to give an even more detailed understanding of quality of life.

Puntos clave

  • This study aims to create a new questionnaire for women with metastatic breast cancer.
  • The goal is to better understand patients' daily experiences and quality of life.
  • Your input through interviews will directly help develop this important tool.
  • Participation will not involve new treatments or change your current medical care.
  • This research could improve future support and care for women like you.

¿Quién puede ser elegible?

This study is looking for women aged 18 or over who have been diagnosed with breast cancer that has spread to other parts of the body. This includes women who are newly diagnosed with metastatic breast cancer, and those whose cancer has returned and spread. Even if the cancer has spread to the brain, you might still be able to join, as long as it hasn't caused major problems with your thinking or memory.

You should either be currently receiving treatment for metastatic breast cancer, or have received treatment in the past and are now being monitored. The type of treatment doesn't usually matter, so this could include chemotherapy, hormone therapy, targeted drugs, radiotherapy, or a combination of these.

To take part, you need to be able to understand and speak the language the questionnaire is given in, and be able to provide your agreement to participate. You won't be able to join if you have very early-stage breast cancer, or if your doctor believes a mental health condition or memory problem would make it difficult for you to take part in interviews.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Tienes 18 años o más?
  2. Do you have breast cancer that has spread to other parts of your body?
  3. Are you currently receiving treatment for metastatic breast cancer, or have you recently been treated?
  4. Can you understand and speak the language used for the questionnaire?
  5. Do you feel comfortable talking about your health and experiences in an interview?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you join this study, your involvement will primarily be through interviews. These interviews are designed to help researchers understand your experiences and feelings about living with metastatic breast cancer. This information will then be used to create the new questionnaire. The study focuses on gathering your insights rather than testing new treatments. Therefore, there are no specific medications, visits to clinics for treatments, or long-term follow-up appointments directly related to the study itself. You will continue with your usual medical care as planned by your healthcare team. The exact number and length of interviews will be explained to you fully before you decide to take part.

Riesgos y beneficios potenciales

A potential benefit of taking part is contributing to a tool that could improve how healthcare professionals understand and support women with metastatic breast cancer in the future. Sharing your experiences could help many others. There are very few direct risks; you might find some questions about your health and feelings to be sensitive, but you won't be asked to do anything that could harm your health. Remember, your participation is completely voluntary, and you can change your mind and stop taking part at any time without affecting your medical care.

Locations (22)

  • Ghent University Hospital
    Código postal verificado
    Gante, Bélgica· Aún no reclutando
  • Centre hospitalier de l'Université de Montreal
    Código postal verificado
    Montreal, Canadá· Aún no reclutando
  • Odette Cancer Center - Sunnybrook Health Sciences Center
    Código postal verificado
    Toronto, Canadá· Reclutamiento
  • Centre Hospitalier Lyon Sud
    Código postal verificado
    Lyon, Francia· Reclutamiento
  • University Hospital of Nimes
    Código postal verificado
    Nîmes, France· Aún no reclutando
  • Centre Hospitalier Universitaire de Saint-Etienne
    Código postal verificado
    Saint-Etienne, France· Aún no reclutando
  • Charité - Universitätsmedizin
    Código postal verificado
    Berlín, Alemania· Aún no reclutando
  • Helios University Hospital
    Código postal verificado
    Wuppertal, Germany· Reclutamiento
  • Tata Memorial Hospital
    Código postal verificado
    Mumbai, India· Aún no reclutando
  • Istituto Nazionale Tumori
    Código postal verificado
    Nápoles, Italia· Reclutamiento
  • Veneto Institute of Oncology
    Código postal verificado
    Padova, Italy· Aún no reclutando
  • Kansai Medical University Hospital
    Código postal verificado
    Osaka, Japón· Reclutamiento

Preguntas comunes

What is 'quality of life' in this study?

It means how well you feel and function in your daily life, including your physical health, emotional wellbeing, and social activities.

Will this study give me a new treatment?

No, this study is about developing a questionnaire, not testing new treatments. You will continue with your usual medical care.

How long will my involvement last?

The study involves interviews. The exact number and length of these will be explained to you before you agree to take part.

Do I have to speak English to take part?

You need to be able to understand and speak the language the questionnaire is given in, which might be English or another European language depending on the centre.

What if I decide I don't want to continue?

You can withdraw from the study at any time, for any reason, without it affecting your medical care or relationship with your healthcare team.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "EORTC Metastatic Breast Cancer Module Development…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.